Tweet
Source: https://www.cidrap.umn.edu/news-pers...cting-covid-19
Only 21% of Americans worried about contracting COVID-19
Stephanie Soucheray | News Reporter | CIDRAP News
| Jun 18, 2021
A new poll shows only 21% of Americans fear contracting COVID-19 from someone they know well, the lowest number since the pandemic began, according to the Associated Press-NORC Center for Public Affairs Research.
Only 25% are concerned that lifted restrictions will lead to more infections in their community. About 40% of those polled said their communities were handling reopening at a correct pace, with 27% thinking it has been done too slowly and 34% feeling restrictions were lifted too hastily.
But in general, most poll respondents said they were resuming pre-pandemic activities, including visiting family and friends, shopping for non-essential items, and dining in bars and restaurants.
Mask wearing, which has been mandated less and less, is also being dropped. In February, 65% of poll respondents said they wore a mask when gathering with anyone outside their households. Now only 37% say they do so.
The poll results come as cases continue to decline across the country. Yesterday the United States reported 10,399 new COVID-19 cases and 281 deaths, according to the Johns Hopkins COVID-19 tracker.
Popularity of Johnson & Johnson vaccine continues to fall
The Centers for Disease Control and Prevention (CDC) COVID Data Tracker shows 377,215,060 COVID-19 vaccine doses have been delivered in the United States and 314,969,386 have been administered, with 147,758,5858 Americans fully vaccinated (65% of US adults have at least one dose). Yesterday was the biggest vaccination day in several weeks, with more than 2 million doses administered.
Only about 4% of the vaccines administered thus far in the United States are the one-dose adenovirus vaccine created by Johnson & Johnson.
Once believed to be a pandemic game changer because of its simple dosing and standard refrigeration, only 11.8 million Johnson & Johnson doses have been administered in the United States so far, the New York Times reports. And only 3.5 million doses have been used since the vaccine was subjected to a 10-day pause in mid-April after it was linked to handful of serious blood clotting events.
Company officials said they were still hopeful the vaccine would have a global impact, adding that 400 million doses have been promised to the African Union.
Other US developments
Only 21% of Americans worried about contracting COVID-19
Stephanie Soucheray | News Reporter | CIDRAP News
| Jun 18, 2021
A new poll shows only 21% of Americans fear contracting COVID-19 from someone they know well, the lowest number since the pandemic began, according to the Associated Press-NORC Center for Public Affairs Research.
Only 25% are concerned that lifted restrictions will lead to more infections in their community. About 40% of those polled said their communities were handling reopening at a correct pace, with 27% thinking it has been done too slowly and 34% feeling restrictions were lifted too hastily.
But in general, most poll respondents said they were resuming pre-pandemic activities, including visiting family and friends, shopping for non-essential items, and dining in bars and restaurants.
Mask wearing, which has been mandated less and less, is also being dropped. In February, 65% of poll respondents said they wore a mask when gathering with anyone outside their households. Now only 37% say they do so.
The poll results come as cases continue to decline across the country. Yesterday the United States reported 10,399 new COVID-19 cases and 281 deaths, according to the Johns Hopkins COVID-19 tracker.
Popularity of Johnson & Johnson vaccine continues to fall
The Centers for Disease Control and Prevention (CDC) COVID Data Tracker shows 377,215,060 COVID-19 vaccine doses have been delivered in the United States and 314,969,386 have been administered, with 147,758,5858 Americans fully vaccinated (65% of US adults have at least one dose). Yesterday was the biggest vaccination day in several weeks, with more than 2 million doses administered.
Only about 4% of the vaccines administered thus far in the United States are the one-dose adenovirus vaccine created by Johnson & Johnson.
Once believed to be a pandemic game changer because of its simple dosing and standard refrigeration, only 11.8 million Johnson & Johnson doses have been administered in the United States so far, the New York Times reports. And only 3.5 million doses have been used since the vaccine was subjected to a 10-day pause in mid-April after it was linked to handful of serious blood clotting events.
Company officials said they were still hopeful the vaccine would have a global impact, adding that 400 million doses have been promised to the African Union.
Other US developments
- New York City's subway system reached 2.5 million customers on Wednesday, the highest level since the beginning of the pandemic, Bloomberg News.
- The CDC has relaxed its warning for cruise travel for the first time since the pandemic began, the Washington Post But the agency is recommending that only fully vaccinated people embark when cruises resume from US ports later this summer.
- Because of the Juneteenth holiday this weekend, the Advisory Committee on Immunization Practices (ACIP) has rescheduled its next meeting, originally to be held today, to Jun 23-25. ACIP was expected to discuss myocarditis incidence in adolescents who've received mRNA vaccines.